Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice - Top-Institutions - MDSpire

Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice

The study points to a possible off-the-shelf cell therapy for solid tumors

  • June 16, 2026

  • 3 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Stanford Medicine
    Stanford Medicine

    Stanford, California

    Key Differentiators

    • Oncology

  • #2

    Stanford School of Medicine
    Stanford School of Medicine

    Stanford, California

    Key Differentiators

    • Oncology

  • #3

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #4

    Dana-Farber Cancer Research Institute
    Dana-Farber Cancer Research Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice

  • June 16, 2026

Related Content

Improving access to therapeutic clinical trials: a randomized controlled trial of GUIDE navigation and reimbursement

Immune–tumor cell ligand–receptor axes driving metabolic reprogramming and therapeutic resistance in cancer

Cerebrovascular thrombosis during pediatric ALL therapy: a case series highlighting temporal association with PEG-asparaginase exposure